Olaratumab (Lartruvo): An Innovative Treatment for Soft Tissue Sarcoma.

about

Olaratumab (Lartruvo): An Innovative Treatment for Soft Tissue Sarcoma.

Item

http://www.wikidata.org/entity/Q55123019

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Olaratumab (Lartruvo): An Innovative Treatment for Soft Tissue Sarcoma.

@en

Olaratumab

@nl

type

Item

label

Olaratumab (Lartruvo): An Innovative Treatment for Soft Tissue Sarcoma.

@en

Olaratumab

@nl

prefLabel

Olaratumab (Lartruvo): An Innovative Treatment for Soft Tissue Sarcoma.

@en

Olaratumab

@nl

P1476

Olaratumab (Lartruvo): An Innovative Treatment for Soft Tissue Sarcoma.

@en

P2093

Khilna Patel

http://www.w3.org/2001/XMLSchema#string

Lindsey Penniman

http://www.w3.org/2001/XMLSchema#string

Sapna Parmar

http://www.w3.org/2001/XMLSchema#string

P2860

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.

Phase I study of olaratumab in Japanese patients with advanced solid tumors.

Frequency of certain established risk factors in soft tissue sarcomas in adults: a prospective descriptive study of 658 cases

Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas.

PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma.

Cancer Statistics, 2017.

P304

267-270

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29719366

http://www.w3.org/2001/XMLSchema#string

P932

5912242

http://www.w3.org/2001/XMLSchema#string